PainRelief.com: What should readers take away from your report?
Response: The dosages studied were much lower than typical recreationally used nowadays. People who are treating migraine with cannabis do not need to use cannabis at dosages that make them “high” to get anti-migraine effects.
PainRelief.com: What recommendations do you have for future research as a result of this study?
Response: We need additional studies to confirm the findings of this study as well as studies with repeated, long-term use to evaluate for rates of medication overuse headache development and rates of cannabis use disorder development.
Disclosures: I have received research funding from Migraine Research Foundation, Novaremed, UCSD Academic Senate, UCSD Department of Anesthesiology RAG, and NIH CTSA Grant UL1TR000100 and has consulted for Eli Lilly & Co., Averitas, Syneos, Schedule 1 Therapeutics, Vectura Fertin, and ShiraTronics. He serves on the editorial board of Pain Medicine (Oxford University Press). .
Citation:
1) Vaporized Cannabis versus Placebo for Acute Migraine: A Randomized Controlled Trial
Authors:Schuster, Nathaniel Wallace, Mark Buse, Dawn Marcotte, Thomas Lee, Euyhyun Liu, Lin Sexton, Michelle
AAN Annual Meeting April 2024
https://index.mirasmart.com/AAN2024/SearchResults.php?q=Schuster
2) Vaporized Cannabis versus Placebo for Acute Migraine: A Randomized Controlled Trial
Nathaniel M. Schuster, Mark S. Wallace, Thomas D. Marcotte, Dawn C. Buse, Euyhyun Lee, Lin Liu, Michelle Sexton
medRxiv 2024.02.16.24302843; doi: https://doi.org/10.1101/2024.02.16.24302843
Note: This article is a preprint and has not been peer-reviewed It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
The information on PainRelief.com is provided for educational purposes only, and is in no way intended to diagnose, cure, or treat any medical or other condition. Always seek the advice of your physician or other qualified health and ask your doctor any questions you may have regarding a medical condition. In addition to all other limitations and disclaimers in this agreement, service provider and its third party providers disclaim any liability or loss in connection with the content provided on this website.
Last Updated on April 16, 2024 by PainRelief.com